glp-1 drug market competition 2025 Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 GLP-1 Receptor Agonist Market Growth
Description
In clinical trials of oral Rybelsus (the previous formulation of the Ozempic pill) in people with type 2 diabetes, people lost around 58 pounds (about 2.5%4% of their baseline weight) after 26 weeks and the higher the dose of the medication, the more weight they lost
Proper hydration is essential, especially since GLP-1 medications slow digestion and may lead to nausea
(Wilding et al., NEJM 2021) Oral semaglutide: Rybelsus approved for T2D in 2019
Every time you remove the vial from refrigeration to draw a dose, you expose the solution to temperature fluctuation
53 Collaboration with other health professionals such as dieticians, primary care physicians and psychologists fosters a deeper understanding of the broad implications of GLP-1 agonist use
